quizartinib
daiichi sankyo
['myeloid', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'quizartinib', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia']
the combination of quizartinib plus chemotherapy yielded better survival outcomes vs chemotherapy alone in the frontline setting of flt3-itd-positive acute myeloid leukemia. #aml #eha2022 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.